Boyar Asset Management Inc. Bristol Myers Squibb CO Transaction History

Boyar Asset Management Inc.

$140 Million
Q2 2024

A detailed history of Boyar Asset Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boyar Asset Management Inc. holds 30,065 shares of BMY stock, worth $1.67 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

30,065

Previous 30,416 1.15%

Holding current value

$1.67 Million

Previous $1.65 Million 24.32%

% of portfolio

0.89%

Previous 1.11%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$40.25 - $52.99 $14,127 - $18,599	-351 Reduced 1.15%	30,065 $1.25 Million
Q1 2024 May 06, 2024	BUY	$47.98 - $54.4 $62,805 - $71,209	1,309 Added 4.5%	30,416 $1.65 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $102,195 - $121,947	-2,108 Reduced 6.75%	29,107 $1.49 Million
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $20,261 - $22,655	-350 Reduced 1.11%	31,215 $1.81 Million
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $8,473 - $9,408	-133 Reduced 0.42%	31,565 $2.02 Million
Q1 2023 Apr 27, 2023	BUY	$65.71 - $74.53 $24,378 - $27,650	371 Added 1.18%	31,698 $2.2 Million
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $27,323 - $32,354	-399 Reduced 1.26%	31,327 $2.25 Million
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $6 - $3,765	-49 Reduced 0.15%	31,726 $2.26 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $227,010 - $250,017	-3,126 Reduced 8.96%	31,775 $2.45 Million
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $13,279 - $15,923	216 Added 0.62%	34,901 $2.55 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $5,363 - $6,252	-100 Reduced 0.29%	34,685 $2.16 Million
Q3 2021 Oct 18, 2021	SELL	$59.17 - $69.31 $4,911 - $5,752	-83 Reduced 0.24%	34,785 $2.06 Million
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $61 - $67	1 Added 0.0%	34,868 $2.33 Million
Q1 2021 May 04, 2021	SELL	$59.34 - $66.74 $17,980 - $20,222	-303 Reduced 0.86%	34,867 $2.2 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $159,882 - $181,175	-2,769 Reduced 7.3%	35,170 $2.18 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $41,062 - $45,502	715 Added 1.92%	37,939 $2.29 Million
Q1 2020 Apr 17, 2020	SELL	$46.4 - $67.43 $23,153 - $33,647	-499 Reduced 1.32%	37,224 $2.08 Million
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $34,791 - $45,382	-707 Reduced 1.84%	37,723 $2.42 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $29,939 - $35,497	-700 Reduced 1.79%	38,430 $1.95 Million
Q2 2019 Aug 06, 2019	SELL	$44.62 - $49.34 $13,519 - $14,950	-303 Reduced 0.77%	39,130 $1.78 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $35,838 - $46,474	-735 Reduced 1.83%	39,433 $2.05 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $14,800 - $17,038	-247 Reduced 0.61%	40,168 $2.54 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $9,470 - $10,325	158 Added 0.39%	40,415 $2.48 Million
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $2.22 Million - $2.57 Million	40,257	40,257 $2.57 Million

Others Institutions Holding BMY

# of Institutions

2,453

Shares Held

1.5B

Call Options Held

29.6M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $118B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boyar Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boyar Asset Management Inc. with notifications on news.

Account

Boyar Asset Management Inc. Bristol Myers Squibb CO Transaction History